PVLA שווי כולל של נכסי החברה Pieris Pharma

The price indicator on the total assets chart for Pieris Pharmaceuticals (PVLA), with a value of 163.66, reflects the dynamics of a company implementing eco-friendly closed-loop water consumption cycles. The business relies on unique Anticalin proteins to combat fibrosis and oncology, ensuring significant pricing power. However, the firm is currently undergoing a painful restructuring due to the failure of several clinical trials, which calls into question the preservation of capital.

Long-term investing requires strict control over the gap between market capitalization and a company's actual assets. For Pieris Pharmaceuticals (PVLA), which lacks revenue and depends on external financing, an analysis of consolidated assets calculated reversely via ROA is critical: it reveals a dangerous degradation of resources against a backdrop of speculative price spikes, signaling a high risk of a sharp correction in the share price.